Checkup

Making Rounds

Upcoming Health Lectures

Mayo Clinic Health Forum presents:

• 'Ears to You and Your Hearing
  with Dr. David Hawkins, Audiology, Thursday, July 21
• Sunbathers Beware! What You Should Know About Skin Cancer
  with Dr. Ali Hendi, Dermatology, Wednesday, Aug. 17

Programs begin at 7 p.m. in Kinne Auditorium, Cannaday Building, at Mayo Clinic.
Reservations: (904) 953-0770.

Volunteers Needed for Clinical Trials

Do you suffer from recurring stomach pain?
If you are a woman over the age of 18 who has experienced the following symptoms during any 12 weeks of the past year, you may be eligible to participate in a clinical research study: early sense of fullness with eating, pain or discomfort in the middle to upper abdomen, bloating and nausea or vomiting.

These are symptoms of a digestive condition called dyspepsia. We are studying if the investigational use of an already approved medication will improve your symptoms of dyspepsia. You must not have been diagnosed with gastroesophageal reflux disease (GERD), active irritable bowel syndrome (IBS) or diabetes requiring insulin treatment. If you qualify, you will be provided with all study examinations and medication. You will receive compensation for your time if you complete this study. To learn more, please contact Marcia Christy in the Clinical Studies Unit at (904) 953-8268.

Are you being treated for osteoporosis?
Mayo Clinic seeks female volunteers over the age of 50 who have been diagnosed with osteoporosis for a research study testing a specific medication combination. The study will test the effectiveness of a medication called teriparatide (Forteo®) when given in conjunction with raloxifene (Evista®) and alendronate. The study is seeking women who have been treated with raloxifene for at least the past 18 months. After two months of screening tests, qualified participants will be randomized to one of two medication groups: teriparatide with raloxifene or teriparatide alone. Participants must take the medications for 18 months and make about nine visits to the clinic. Compensation will be offered. For more information, call (904) 953-0703.

Stress urinary incontinence study
Mayo Clinic physicians are studying a new treatment for stress urinary incontinence in women. The new therapy is given in the office without the need for anesthesia or major surgery. The study involves the injection of soft-tissue bulking agents in the urethra/bladder neck to control stress urinary incontinence. Study participants will be randomly assigned to receive either the product being tested or one that has already been approved by the Food and Drug Administration for treating urinary incontinence. Women over the age of 18 who have had stress urinary incontinence for at least one year are eligible. For more information, please call (904) 953-6971.